NCT04364711View on ClinicalTrials.gov

EuRopean Study of MAjor Infectious Disease Syndromes Related to COVID-19

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

June 18, 2020

Primary Completion Date

December 16, 2022

Study Completion Date

December 16, 2022

Conditions
COVID-19SARS-CoV 2
Trial Locations (11)

Unknown

Tartu University, Tartu

Attikon Hospital, Athens

Brescia Hospital, Brescia

UMC Utrecht, Utrecht

Nat.Inst. For Inf. Dis. Prof. Dr. Matei Bals, Bucharest

Clinical Center of Podgorica, Podgorica

Clinical Center of Serbia, Belgrade

Clinical Center of Kragujevac, Kraljevo

Hospital Germans Trias i Pujol, Barcelona

Regional Hospital de Malaga, Málaga

Hospital Virgen Macarena, Seville

All Listed Sponsors
lead

UMC Utrecht

OTHER

NCT04364711 - EuRopean Study of MAjor Infectious Disease Syndromes Related to COVID-19 | Biotech Hunter | Biotech Hunter